Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Michael Maes, George Anderson, Marta Kubera & Michael Berk. (2014) Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?. Expert Opinion on Therapeutic Targets 18:5, pages 495-512.
Read now
Read now
Shili Xu & Nouri Neamati. (2013) gp130: a promising drug target for cancer therapy. Expert Opinion on Therapeutic Targets 17:11, pages 1303-1328.
Read now
Read now
Articles from other publishers (67)
Ruihan Xiao, Chunyan Lei, Yi Zhang & Meixia Zhang. (2023) Interleukin-6 in retinal diseases: From pathogenesis to therapy. Experimental Eye Research 233, pages 109556.
Crossref
Crossref
Jingjing RenXiao-Qi WangTetsushi NakaoPeter LibbyGuo-Ping Shi. (2023) Differential Roles of Interleukin-6 in Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Cardiometabolic Diseases. Cardiology Discovery.
Crossref
Crossref
Sajida Maryam, Katarzyna Krukiewicz, Ihtisham Ul Haq, Awal Ayaz Khan, Galal Yahya & Simona Cavalu. (2023) Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring. Journal of Clinical Medicine 12:9, pages 3127.
Crossref
Crossref
Shenghong Zhang, Baili Chen, Bangmao Wang, Hong Chen, Yan Li, Qian Cao, Jie Zhong, Ming-Jium Shieh, Zhihua Ran, Tongyu Tang, Ming Yang, Beibei Xu, Qiang Wang, Yunjie Liu, Lijia Ma, Xiaolin Wang, Nan Zhang, Su Zhang, Wenyu Guo, Liang Huang, Stefan Schreiber & Minhu Chen. (2023) Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis. JAMA 329:9, pages 725.
Crossref
Crossref
Sabine Karam, Mohamad Haidous, Virginie Royal & Nelson Leung. (2023) Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review. Kidney International 103:3, pages 473-484.
Crossref
Crossref
Erum Zafar, Muhammad Faisal Maqbool, Asia Iqbal, Amara Maryam, Hafiz Abdullah Shakir, Muhammad Irfan, Muhammad Khan, Yongming Li & Tonghui Ma. (2021) A comprehensive review on anticancer mechanism of bazedoxifene. Biotechnology and Applied Biochemistry 69:2, pages 767-782.
Crossref
Crossref
Stefan Rose-John. (2021) Blocking only the bad side of IL-6 in inflammation and cancer. Cytokine 148, pages 155690.
Crossref
Crossref
Jil-Madeline Homeier, Katrin Bundkirchen, Marcel Winkelmann, Tilman Graulich, Borna Relja, Claudia Neunaber & Christian Macke. (2021) Selective Inhibition of IL-6 Trans-Signaling Has No Beneficial Effect on the Posttraumatic Cytokine Release after Multiple Trauma in Mice. Life 11:11, pages 1252.
Crossref
Crossref
Leekyung Kim, Sun-Ae Park, Hyemin Park, Heejung Kim & Tae-Hwe Heo. (2021) Bazedoxifene, a GP130 Inhibitor, Modulates EMT Signaling and Exhibits Antitumor Effects in HPV-Positive Cervical Cancer. International Journal of Molecular Sciences 22:16, pages 8693.
Crossref
Crossref
Stefan Schreiber, Konrad Aden, Joana P. Bernardes, Claudio Conrad, Florian Tran, Hanna Höper, Valery Volk, Neha Mishra, Johanna Ira Blase, Susanna Nikolaus, Johannes Bethge, Tanja Kühbacher, Christoph Röcken, Minhu Chen, Ian Cottingham, Niclas Petri, Birgitte B. Rasmussen, Juliane Lokau, Lennart Lenk, Christoph Garbers, Friedrich Feuerhake, Stefan Rose-John, Georg H. Waetzig & Philip Rosenstiel. (2021) Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease. Gastroenterology 160:7, pages 2354-2366.e11.
Crossref
Crossref
. (2021) IL-6 as a Surrogate Biomarker: The IL-6 Clinical Value for the Diagnosis of Insulin Resistance and Type 2 Diabetes.. SunKrist Endocrinology and Metabolism Research Journal, pages 1-13.
Crossref
Crossref
Andrew N. Wilkinson, Karshing ChangRachel D. KunsAndrea S. Henden, Simone A. MinnieKathleen S. EnsbeyAndrew D. CloustonPing Zhang, Motoko KoyamaJuan Hidalgo, Stefan Rose-John, Antiopi Varelias, Slavica VuckovicKate H. Gartlan & Geoffrey R. Hill. (2019) IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling. Blood 134:23, pages 2092-2106.
Crossref
Crossref
T. A. Lisitsyna, D. Yu. Veltishchev, A. M. Lila & E. L. Nasonov. (2019) Interleukin 6 as a pathogenic factor mediating clinical manifestations and a therapeutic target for rheumatic diseases and depressive disorders. Rheumatology Science and Practice 57:3, pages 318-327.
Crossref
Crossref
Rhiannon Morris, Nadia J. Kershaw & Jeffrey J. Babon. (2018) The molecular details of cytokine signaling via the JAK/STAT pathway. Protein Science 27:12, pages 1984-2009.
Crossref
Crossref
Karsten Lücke, Isabell Yan, Sonja Krohn, Annika Volmari, Stefanie Klinge, Joanna Schmid, Valéa Schumacher, Oliver M. Steinmetz, Stefan Rose-John & Hans-Willi Mittrücker. (2018) Control of Listeria monocytogenes infection requires classical IL-6 signaling in myeloid cells. PLOS ONE 13:8, pages e0203395.
Crossref
Crossref
Mohamad Akbari & Vahideh Hassan-Zadeh. (2018) IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology 26:3, pages 685-698.
Crossref
Crossref
Katja Prystaz, Kathrin Kaiser, Anna Kovtun, Melanie Haffner-Luntzer, Verena Fischer, Anna E. Rapp, Astrid Liedert, Gudrun Strauss, Georg H. Waetzig, Stefan Rose-John & Anita Ignatius. (2018) Distinct Effects of IL-6 Classic and Trans -Signaling in Bone Fracture Healing. The American Journal of Pathology 188:2, pages 474-490.
Crossref
Crossref
Klaus Heese. (2017) Functional repertoire of interleukin-6 in the central nervous system – a review. Restorative Neurology and Neuroscience 35:6, pages 693-701.
Crossref
Crossref
Roberto Cuevas-Olguin, Eric Esquivel-Rendon, Jorge Vargas-Mireles, Francisco Garcia-Oscos, Marcela Miranda-Morales, Humberto Salgado, Stefan Rose-John & Marco Atzori. (2017) Interleukin 6 trans-signaling regulates basal synaptic transmission and sensitivity to pentylenetetrazole-induced seizures in mice. Synapse 71:9, pages e21984.
Crossref
Crossref
Giuseppe Lopalco, Claudia Fabiani, Jurgen Sota, Orso Maria Lucherini, Gian Marco Tosi, Bruno Frediani, Florenzo Iannone, Mauro Galeazzi, Rossella Franceschini, Donato Rigante & Luca Cantarini. (2017) IL-6 blockade in the management of non-infectious uveitis. Clinical Rheumatology 36:7, pages 1459-1469.
Crossref
Crossref
Qian Liu, Shengnan Yu, Anping Li, Hanxiao Xu, Xinwei Han & Kongming Wu. (2017) Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment. Tumor Biology 39:6, pages 101042831771244.
Crossref
Crossref
Hua Su, Chun-Tao Lei & Chun Zhang. (2017) Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update. Frontiers in Immunology 8.
Crossref
Crossref
K Aden, A Breuer, A Rehman, H Geese, F Tran, J Sommer, G H Waetzig, T M Reinheimer, S Schreiber, S Rose-John, J Scheller & P Rosenstiel. (2016) Classic IL-6R signalling is dispensable for intestinal epithelial proliferation and repair. Oncogenesis 5:11, pages e270-e270.
Crossref
Crossref
Neele Schumacher, Stefanie Schmidt, Jeanette Schwarz, Dana Dohr, Juliane Lokau, Jürgen Scheller, Christoph Garbers, Athena Chalaris, Stefan Rose-John & Björn Rabe. (2016) Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation. The Journal of Immunology 197:9, pages 3705-3715.
Crossref
Crossref
Xiaojuan Wu, Yang Cao, Hui Xiao, Chenglong Li & Jiayuh Lin. (2016) Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy. Molecular Cancer Therapeutics 15:11, pages 2609-2619.
Crossref
Crossref
Janina Wolf, Georg H. Waetzig, Athena Chalaris, Torsten M. Reinheimer, Henning Wege, Stefan Rose-John & Christoph Garbers. (2016) Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling. Journal of Biological Chemistry 291:31, pages 16186-16196.
Crossref
Crossref
Isabell Yan, Jeanette Schwarz, Karsten Lücke, Neele Schumacher, Valéa Schumacher, Stefanie Schmidt, Björn Rabe, Paul Saftig, Marjo Donners, Stefan Rose-John, Hans-Willi Mittrücker & Athena Chalaris. (2016) ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Rα from the cell surface of leukocytes during inflammatory responses. Journal of Leukocyte Biology 99:5, pages 749-760.
Crossref
Crossref
Juliane Lokau, Rebecca Nitz, Maria Agthe, Niloufar Monhasery, Samadhi Aparicio-Siegmund, Neele Schumacher, Janina Wolf, Katja Möller-Hackbarth, Georg H. Waetzig, Joachim Grötzinger, Gerhard Müller-Newen, Stefan Rose-John, Jürgen Scheller & Christoph Garbers. (2016) Proteolytic Cleavage Governs Interleukin-11 Trans-signaling. Cell Reports 14:7, pages 1761-1773.
Crossref
Crossref
Janina Wolf, Georg H. Waetzig, Torsten M. Reinheimer, Jürgen Scheller, Stefan Rose-John & Christoph Garbers. (2016) A soluble form of the interleukin-6 family signal transducer gp130 is dimerized via a C-terminal disulfide bridge resulting from alternative mRNA splicing. Biochemical and Biophysical Research Communications 470:4, pages 870-876.
Crossref
Crossref
Ather Muneer. (2016) The Neurobiology of Bipolar Disorder: An Integrated Approach. Chonnam Medical Journal 52:1, pages 18.
Crossref
Crossref
Juliane Lokau, Maria Agthe & Christoph Garbers. (2016) Generation of Soluble Interleukin-11 and Interleukin-6 Receptors: A Crucial Function for Proteases during Inflammation. Mediators of Inflammation 2016, pages 1-10.
Crossref
Crossref
Athena Chalaris, Stefan Rose-John & Christoph Garbers. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology
476
484
.
Fei Li, Zhenzhong Zhang, Teng Cheng, Rui Wei, Yun Dai, Mengqin Lv, Danfeng Luo, Xiaohua Zhu, Ding Ma, Ling Xi, Qingjian Dong & Xiangyi Ma. (2015) SPECT imaging of interleukin-6 receptor in ovarian tumor xenografts with a novel radiotracer of 99mTc-HYNIC-Aca-LSLITRL. Amino Acids 48:1, pages 91-101.
Crossref
Crossref
Reinhild Holmer, Georg H. Wätzig, Sanjay Tiwari, Stefan Rose-John & Holger Kalthoff. (2015) Interleukin-6 trans-signaling increases the expression of carcinoembryonic antigen-related cell adhesion molecules 5 and 6 in colorectal cancer cells. BMC Cancer 15:1.
Crossref
Crossref
Stefan Rose-John. (2015) The soluble interleukin-6 receptor and related proteins. Best Practice & Research Clinical Endocrinology & Metabolism 29:5, pages 787-797.
Crossref
Crossref
Freya A. Goumas, Reinhild Holmer, Jan-Hendrik Egberts, Artur Gontarewicz, Carola Heneweer, Ulf Geisen, Charlotte Hauser, Maria-Margarete Mende, Karen Legler, Christoph Röcken, Thomas Becker, Georg H. Waetzig, Stefan Rose-John & Holger Kalthoff. (2015) Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer. International Journal of Cancer 137:5, pages 1035-1046.
Crossref
Crossref
Christoph Becker-Pauly & Stefan Rose-John. 2015. Matrix Metalloproteinase Biology. Matrix Metalloproteinase Biology
115
130
.
Michael Luig, Malte A. Kluger, Boeren Goerke, Matthias Meyer, Anna Nosko, Isabell Yan, Jürgen Scheller, Hans-Willi Mittrücker, Stefan Rose-John, Rolf A.K. Stahl, Ulf Panzer & Oliver M. Steinmetz. (2015) Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN. Journal of the American Society of Nephrology 26:7, pages 1597-1607.
Crossref
Crossref
Christoph Garbers, Samadhi Aparicio-Siegmund & Stefan Rose-John. (2015) The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition. Current Opinion in Immunology 34, pages 75-82.
Crossref
Crossref
Annamaria Ruzzo, Vincenzo Catalano, Emanuele Canestrari, Elisa Giacomini, Daniele Santini, Giuseppe Tonini, Bruno Vincenzi, Giammaria Fiorentini, Mauro Magnani & Francesco Graziano. (2014) Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy. BMC Cancer 14:1.
Crossref
Crossref
Leonard H. Calabrese & Stefan Rose-John. (2014) IL-6 biology: implications for clinical targeting in rheumatic disease. Nature Reviews Rheumatology 10:12, pages 720-727.
Crossref
Crossref
Janina Wolf, Stefan Rose-John & Christoph Garbers. (2014) Interleukin-6 and its receptors: A highly regulated and dynamic system. Cytokine 70:1, pages 11-20.
Crossref
Crossref
Julia Müller, Simone Gorressen, Maria Grandoch, Kathrin Feldmann, Inga Kretschmer, Stefan Lehr, Zhaoping Ding, Joachim P. Schmitt, Jürgen Schrader, Christoph Garbers, Gerd Heusch, Malte Kelm, Jürgen Scheller & Jens W. Fischer. (2014) Interleukin-6-dependent phenotypic modulation of cardiac fibroblasts after acute myocardial infarction. Basic Research in Cardiology 109:6.
Crossref
Crossref
A. Saini, S. H. Faulkner, H. Moir, P. Warwick, J. A. King & M. A. Nimmo. (2014) Interleukin-6 in combination with the interleukin-6 receptor stimulates glucose uptake in resting human skeletal muscle independently of insulin action. Diabetes, Obesity and Metabolism 16:10, pages 931-936.
Crossref
Crossref
Dan Qu, Jian Liu, Chi Wai Lau & Yu Huang. (2014) IL-6 in diabetes and cardiovascular complications. British Journal of Pharmacology 171:15, pages 3595-3603.
Crossref
Crossref
Jan Sommer, Christoph Garbers, Janina Wolf, Ahmad Trad, Jens M. Moll, Markus Sack, Rainer Fischer, Joachim Grötzinger, Georg H. Waetzig, Doreen M. Floss & Jürgen Scheller. (2014) Alternative Intronic Polyadenylation Generates the Interleukin-6 Trans-signaling Inhibitor sgp130-E10. Journal of Biological Chemistry 289:32, pages 22140-22150.
Crossref
Crossref
Reinhild Holmer, Freya A Goumas, Georg H Waetzig, Stefan Rose-John & Holger Kalthoff. (2014) Interleukin-6: a villain in the drama of pancreatic cancer development and progression. Hepatobiliary & Pancreatic Diseases International 13:4, pages 371-380.
Crossref
Crossref
Rachelle W Johnson, Holly J Brennan, Christina Vrahnas, Ingrid J Poulton, Narelle E McGregor, Therese Standal, Emma C Walker, Thuan-Tzen Koh, Huynh Nguyen, Nicole C Walsh, Mark R Forwood, T John Martin & Natalie A Sims. (2014) The Primary Function of gp130 Signaling in Osteoblasts Is To Maintain Bone Formation and Strength, Rather Than Promote Osteoclast Formation. Journal of Bone and Mineral Research 29:6, pages 1492-1505.
Crossref
Crossref
SHU-WEI WANG & YUE-MING SUN. (2014) The IL-6/JAK/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer. International Journal of Oncology 44:4, pages 1032-1040.
Crossref
Crossref
S. Schreiber & O. Bachmann. (2014) Neue Biologika für die Behandlung chronisch-entzündlicher DarmerkrankungenNew biologics for treatment of chronic inflammatory bowel diseases. Der Internist 55:4, pages 367-376.
Crossref
Crossref
Shashi Gupta, Masao Hirota, Sheela M. Waugh, Ikuo Murakami, Tomoki Suzuki, Masahiro Muraguchi, Masafumi Shibamori, Yuichi Ishikawa, Thale C. Jarvis, Jeffrey D. Carter, Chi Zhang, Bharat Gawande, Michael Vrkljan, Nebojsa Janjic & Daniel J. Schneider. (2014) Chemically Modified DNA Aptamers Bind Interleukin-6 with High Affinity and Inhibit Signaling by Blocking Its Interaction with Interleukin-6 Receptor. Journal of Biological Chemistry 289:12, pages 8706-8719.
Crossref
Crossref
Maximilian J. Waldner & Markus F. Neurath. (2014) Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development. Seminars in Immunology 26:1, pages 75-79.
Crossref
Crossref
Poonam Kothari, Roberto Pestana, Rim Mesraoua, Rim Elchaki, K. M. Faisal Khan, Andrew J. Dannenberg & Domenick J. Falcone. (2014) IL-6–Mediated Induction of Matrix Metalloproteinase-9 Is Modulated by JAK-Dependent IL-10 Expression in Macrophages. The Journal of Immunology 192:1, pages 349-357.
Crossref
Crossref
Soo A. Oh, Hyejin Byun, Eunsu Jang & Sangkyun Jeong. (2014) Identification of cis-regulatory variations in the IL6R gene through the inheritance assessment of allelic transcription. Biochimica et Biophysica Acta (BBA) - General Subjects 1840:1, pages 637-644.
Crossref
Crossref
Daisuke Kamimura, Yasunobu Arima, Toshio Hirano, Hideki Ogura & Masaaki Murakami. 2014. Cytokine Frontiers. Cytokine Frontiers
53
78
.
Jorge Esparza-Gordillo, Heidi Schaarschmidt, Liming Liang, William Cookson, Anja Bauerfeind, Min-Ae Lee-Kirsch, Katja Nemat, John Henderson, Lavinia Paternoster, John I. Harper, Elisabeth Mangold, Markus M. Nothen, Franz Rüschendorf, Tamara Kerscher, Ingo Marenholz, Anja Matanovic, Susanne Lau, Thomas Keil, Carl-Peter Bauer, Michael Kurek, Andrzej Ciechanowicz, Milan Macek, Andre Franke, Michael Kabesch, Norbert Hubner, Gonçalo Abecasis, Stephan Weidinger, Miriam Moffatt & Young-Ae Lee. (2013) A functional IL-6 receptor (IL6R) variant is a risk factor for persistent atopic dermatitis. Journal of Allergy and Clinical Immunology 132:2, pages 371-377.
Crossref
Crossref
Ralf J. Ludwig. (2013) Clinical Presentation, Pathogenesis, Diagnosis, and Treatment of Epidermolysis Bullosa Acquisita. ISRN Dermatology 2013, pages 1-25.
Crossref
Crossref
Malgorzata Wegner, Aleksandra Araszkiewicz, Maria Piorunska-Stolzmann, Bogna Wierusz-Wysocka & Dorota Zozulinska-Ziolkiewicz. (2013) Association Between IL-6 Concentration and Diabetes-Related Variables in DM1 Patients with and without Microvascular Complications. Inflammation 36:3, pages 723-728.
Crossref
Crossref
Wangko LundströmSteven HighfillScott T. R. WalshStephanie Beq, Elizabeth MorseIngrid KockumLars Alfredsson, Tomas OlssonJan HillertCrystal L. Mackall. (2013) Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity. Proceedings of the National Academy of Sciences 110:19.
Crossref
Crossref
Hong Zhang, Patrick Neuhöfer, Liang Song, Björn Rabe, Marina Lesina, Magdalena U. Kurkowski, Matthias Treiber, Thomas Wartmann, Sara Regnér, Henrik Thorlacius, Dieter Saur, Gregor Weirich, Akihiko Yoshimura, Walter Halangk, Joseph P. Mizgerd, Roland M. Schmid, Stefan Rose-John & Hana Algül. (2013) IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality. Journal of Clinical Investigation 123:3, pages 1019-1031.
Crossref
Crossref
Unni Krishna S.R.L. Samavedam, Kathrin Kalies, Jürgen Scheller, Hengameh Sadeghi, Yask Gupta, Marcel F. Jonkman, Enno Schmidt, Jürgen Westermann, Detlef Zillikens, Stefan Rose-John & Ralf J. Ludwig. (2013) Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction. Journal of Autoimmunity 40, pages 74-85.
Crossref
Crossref
M. J. P. Welters & S. H. van der Burg. 2013. The Tumor Immunoenvironment. The Tumor Immunoenvironment
107
133
.
Christian Kellner & Matthias Peipp. 2013. Molecular and Cellular Mechanisms of Antibody Activity. Molecular and Cellular Mechanisms of Antibody Activity
251
284
.
Dörthe Schaue, Evelyn L. Kachikwu & William H. McBride. (2012) Cytokines in Radiobiological Responses: A Review. Radiation Research 178:6, pages 505-523.
Crossref
Crossref
Marco AtzoriFrancisco Garcia-Oscos & Jose Alfredo Mendez. (2012) Role of IL-6 in the etiology of hyperexcitable neuropsychiatric conditions: experimental evidence and therapeutic implications. Future Medicinal Chemistry 4:17, pages 2177-2192.
Crossref
Crossref
Stefan Rose-John & Athena Chalaris. (2012) ADAM17: a potential therapeutic target for rheumatoid arthritis?. International Journal of Clinical Rheumatology 7:4, pages 357-359.
Crossref
Crossref
Christoph Garbers, Heike M. Hermanns, Fred Schaper, Gerhard Müller-Newen, Joachim Grötzinger, Stefan Rose-John & Jürgen Scheller. (2012) Plasticity and cross-talk of Interleukin 6-type cytokines. Cytokine & Growth Factor Reviews 23:3, pages 85-97.
Crossref
Crossref